Market Minds Advisory
Laboratory Supplies Market

Laboratory Supplies Market: Single-Use Consumables Reshape the Bench

Biopharma and academic laboratories are converting from reusable glassware toward single-use plasticware and filtration consumables as contamination control requirements make sterility assurance a recurring procurement line rather than a one-time purchase.

Lead Analyst

Alice Ballenger

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$48.5BMarket Size 2025
2036 FORECAST VALUE$96.0BBase Case , 2026 to 2036
CAGR 2026 TO 20366.4 %Bull 7.6% / Bear 5.2%
INCREMENTAL OPPORTUNITY$44.4BNet 10- year value creation
EXPANSION MULTIPLE1.86x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory

Laboratory supplies are shifting from a reusable, capital-adjacent category into a recurring single-use consumable relationship, as contamination control requirements convert sterility assurance into a line item labs reorder rather than an asset they wash and reuse. Filtration products are capturing that shift fastest across most facility types.
Filtration products lead every other category on growth as biopharma laboratories convert bioprocessing and sample preparation workflows toward single-use, pre-sterilized formats. India has become the fastest-growing single country, driven by its expanding contract research sector and biopharma manufacturing base. North America still commands the largest share of spending given its concentration of biopharma R&D investment and academic institutions nationwide. Pipette consumables remain second-fastest overall today.
Competitive character remains fragmented among large diversified life sciences suppliers, evaluated consistently on a revenue basis across plasticware, glassware, filtration, and consumable product lines combined rather than on unit price alone. Regulatory momentum favors the category directly: expanding good laboratory practice and biosafety documentation requirements are pushing labs toward certified, traceable consumables well ahead of typical procurement contract renewal cycles, a dynamic several smaller suppliers have not yet fully priced into their roadmaps.
Market Definition
The laboratory supplies market covers plasticware and labware consumables, glassware, filtration products, pipettes and liquid handling consumables, storage and cryogenic supplies, and personal protective equipment and cleanroom supplies used in academic, biopharma, and clinical research laboratories. It excludes capital laboratory instrumentation such as incubators, centrifuges, and analytical instruments, and excludes reagents and diagnostic assay kits sold as standalone chemical products.
Base Year Value
$48.5B in 2025 (MMA Primary Research Dataset, August 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
6.4% base case. Bull 7.6%. Bear 5.2%.
Fastest Growth Segment
Filtration Products: 9.8% CAGR
Fastest Growth Country
India: 10.2% CAGR
Fastest Growth Region
South Asia and Pacific: 8.5% CAGR
Largest Region
North America: 32% of 2025 global value
Market Leaders
Thermo Fisher Scientific Inc., Merck KGaA, Avantor, Inc., Corning Incorporated, Eppendorf SE. Source: MMA Analysis based on company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Laboratory Supplies Market Forecast Scenarios

laboratory-supplies-market-size-forecast-scenario-1787304685715
Laboratory supplies demand grew steadily but unevenly between 2020 and 2025. Pandemic-era vaccine and diagnostic research briefly accelerated consumable orders through 2021, then expanding cell and gene therapy research volume sustained that momentum, lifting historical growth to an estimated 5.4% compound rate. That research investment wave took longer to translate into recurring consumable orders than most suppliers initially expected.
The base case assumes 6.4% annual growth through 2036, anchored on three mechanisms. First, expanding biopharma and cell and gene therapy research investment keeps pulling laboratories toward single-use, pre-sterilized consumable formats across both developed and emerging markets. Second, growing academic and contract research organization capacity keeps expanding baseline consumable demand regardless of any single supplier's specific product mix. Third, biosafety documentation requirements keep converting large research institutions toward certified, traceable supply chains ahead of typical procurement renewal timelines.
A bull case builds if cell and gene therapy research investment accelerates faster than currently expected, pushing growth toward 7.6% as more laboratories scale translational research programs. The bear risk is research funding constraint: if academic and biopharma capital spending slows more than anticipated, consumable order volume could grow well below expectations, capping growth near 5.2% across the forecast period.

From Reusable Glassware to a Recurring Consumable Relationship

Laboratory supplies remain a well-established consumables category, but the market is undergoing a genuine, lasting shift as contamination control requirements and expanding biopharma research volume convert reusable glassware from a default choice into a workflow liability. Research volume still drives baseline demand, but sterility assurance and traceability increasingly decide which supplier captures a laboratory's long-term consumable relationship.
MARKET CONCENTRATION39% CR5Five suppliers hold just under two-fifths of category revenue
AVERAGE SELLING PRICE$0.34 per pipette tip unitBlended price across plasticware and liquid handling consumable formats
LEADING PRODUCT CATEGORY SHAREPlasticware, 31%One product category still dominates total shipped unit volume
DISTRIBUTION CHANNEL CONCENTRATION58% via distributor networksDistributors handle more than half of total order volume
SINGLE-USE CONVERSION RATE44% of new specificationsSingle-use consumables remain under half of new lab specifications
INPUT COST SHARE36% of unit COGSPolymer resin and specialty glass feedstock dominate production cost
Suppliers compete less on unit price alone than on demonstrated supply chain reliability and certification depth, since large laboratories increasingly specify vendors with validated sterility and traceability documentation over suppliers selling consumables as an undifferentiated commodity product. Manufacturing remains concentrated in the United States, Germany, and China, while India's domestic contract research and manufacturing sector is expanding rapidly to serve its own growing biopharma base.
The next decade will be shaped by two forces pulling in the same direction: expanding cell and gene therapy research finally scaling from academic proof-of-concept into commercial translational programs, and contract research organization capacity growing fast enough to expand total consumable demand regardless of which specific product mix a given lab specifies. Both push investment toward single-use, certified formats even as smaller labs weigh consumable cost against still-developing budget clarity in several regional markets.
"Nobody budgets for glassware breakage anymore. They budget for a box of sterile plastic that shows up on schedule. That is the entire category shift."
Director, Life Sciences Consumables and Supply Chain Practice · MMA Medical Devi

Market Trends

Single-Use Filtration Adoption Accelerates Across Bioprocessing

Biopharma laboratories scaling cell and gene therapy research and early-stage bioprocessing are converting filtration workflows from reusable, autoclaved hardware into single-use, pre-sterilized filtration consumables that eliminate cross-contamination risk between production batches. This is pushing laboratories to requalify filtration specifications ahead of typical procurement renewal cycles, since contamination events in cell therapy research carry both financial and regulatory consequences that reusable systems increasingly cannot adequately mitigate. Suppliers with validated single-use filtration platforms are capturing disproportionate share of this conversion wave as additional biopharma programs scale from bench to translational research each year.
Market Impact: Adds 3.4 million annual laboratory

Automated Liquid Handling Expands Specialized Consumable Demand

Growing adoption of automated liquid handling platforms across biopharma and academic laboratories is converting standard pipette tip specifications into automation-compatible, low-retention consumable formats engineered specifically for robotic dispensing accuracy at high throughput. This is opening genuinely new consumable specification volume among laboratories whose existing manual-format tips cannot reliably support automated workflows without costly requalification of established protocols and validated dispensing procedures across their platforms and facilities. Suppliers with validated automation-compatible consumable lines are capturing disproportionate share of this expanding automation adoption as more laboratories convert manual workflows to robotic platforms nationwide each year.
Market Impact: Compresses procurement cycles by 7

Market Opportunities and Growth Drivers

Expanding Biopharma Research Investment Sustains Baseline Demand

Academic and biopharma research investment continues expanding across nearly every major market tracked in this report, driving growing consumable demand that persists regardless of which specific product format a given laboratory ultimately specifies for its research program. This demand base gives the category resilience that pure single-use conversion trends alone would not provide, since underlying research investment keeps expanding even as consumable specifications shift toward certified, single-use formats across the industry. Suppliers investing in both standard and premium certified product lines are capturing disproportionate share of this expanding research base as laboratories increasingly span both academic and translational research activities.
Market Impact: Adds 26% cost premium

Biosafety Documentation Requirements Compress Procurement Cycles

Expanding biosafety and good laboratory practice documentation requirements for regulated research are compressing the effective timeline laboratories have to validate and deploy certified, traceable consumable supply chains, converting what used to be a gradual procurement decision into a compliance deadline tied to specific institutional audit schedules and inspection windows. This is forcing laboratory procurement teams to requalify supplier specifications faster than typical contract renewal cycles would otherwise allow across affected institutions. Suppliers with pre-validated, audit-ready documentation are converting this regulatory pressure into meaningfully faster procurement wins across major research accounts nationwide.
Market Impact: Limits adoption to 44% of specifica

Market Restraints and Challenges

Single-Use Cost Premium Slows Full Conversion

Single-use plasticware and filtration consumables carry a meaningful per-unit cost premium over reusable glassware in most current procurement configurations, creating genuine budget friction for cost-sensitive academic laboratories evaluating conversion against thin research grant margins already under pressure from broader institutional cost increases. The root cause is that single-use manufacturing requires validated sterile packaging and quality control steps that reusable glassware production does not require at all under most current regulatory frameworks. Suppliers are mitigating this by publishing total-cost-of-ownership data that weighs labor savings and contamination risk reduction against the higher unit price directly.
Market Impact: Adds 22% single-use filtration volu

Plastic Waste Concerns Constrain Full-Scale Single-Use Adoption

Growing institutional sustainability commitments and plastic waste reduction policies are creating genuine friction for laboratories evaluating further single-use consumable conversion, since single-use plasticware generates meaningfully more laboratory waste volume than the reusable glassware it typically replaces across a comparable research workload. The underlying cause is that most single-use laboratory plastics remain difficult to recycle given contamination concerns and mixed-material construction that complicates standard recycling stream processing. Suppliers are mitigating this by developing recyclable and bio-based consumable formats, helping laboratories reconcile single-use contamination control benefits against institutional sustainability commitments without abandoning either priority entirely.
Market Impact: Adds 18% automated consumable deman
3 additional market trends, 4 additional growth drivers, and 2 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

MMA segments the market by product type, the classification laboratory procurement teams use when specifying consumables and comparing supplier capability across competing purchasing decisions. This avoids blending upstream material chemistry with the downstream application categories that define how laboratory supplies are actually purchased and used across every major research decision made across institutions today.
laboratory-supplies-market-market-share-analysis-1787304686248

Filtration Products

Filtration products, including single-use membrane filters, syringe filters, and bioprocessing filtration consumables, remain the fastest-growing category as biopharma laboratories convert contamination-sensitive workflows away from reusable hardware toward validated, pre-sterilized single-use formats. Growth concentrates wherever bioprocessing research intersects with contamination control requirements, particularly across North America and increasingly India's rapidly expanding contract research base. Merck KGaA and Corning have each expanded filtration production capacity substantially, recognizing that validated sterility documentation, not filtration performance alone, decides which supplier captures a laboratory's long-term consumable relationship. At a 9.8% forecast CAGR, roughly 1.5 times the market average, this segment is pulling capital investment toward single-use production capacity faster than any other category tracked here.
CAGR 9.8%

Pipettes and Liquid Handling Consumables

Pipettes and liquid handling consumables, including manual and automation-compatible pipette tips, track automated workflow adoption more directly than any other segment, making automation-compatible consumable specification a disproportionate growth driver for this category specifically. Eppendorf and Thermo Fisher Scientific lead on installed base scale, while newer entrants increasingly compete on low-retention formulation and integration with automated liquid handling robotics rather than unit price alone. Demand here is tied more closely to automation adoption pace than to overall laboratory headcount growth alone, since a single automated platform can consume consumable volume equivalent to several manual researchers. This segment's growth trajectory now depends heavily on how quickly laboratories convert manual workflows to robotic liquid handling platforms.
CAGR 8.6%
Full segment breakdown across 6 segments available in the complete report.

Regional Architecture and Country Demand Map

North America commands the largest share of spending given its concentration of biopharma R&D investment, while India's contract research sector and South Asia and Pacific's biopharma manufacturing base anchor the fastest-growing pipelines. Western Europe and East Asia contribute steady, gradually expanding demand of their own.

North America

The United States anchors regional demand through its dense concentration of biopharma R&D investment, academic medical centers, and contract research organizations that drive the largest single national consumable order volume tracked in this report. Canada contributes a smaller, steadily growing demand base benefiting from proximity to the same supplier distribution networks and shared research funding programs serving the broader scientific community. Deeper capital availability for laboratory infrastructure and a larger installed base of academic and biopharma research institutions give the region durable spending power even as unit growth moderates relative to faster-growing markets. Growth stays healthy but trails East Asia and South Asia and Pacific because the region's largest institutions have already completed much of their initial single-use conversion.
Share: 32% | CAGR: 5.8% (2026 to 2036)

Western Europe

Germany anchors both regional consumable manufacturing depth and demand, home to established laboratory supply manufacturers and a dense biopharma research base whose laboratories supply the broader European market. France and the United Kingdom follow with steady demand tied to national research funding programs increasingly favoring certified, traceable consumable supply chains in procurement decisions. Regulatory pressure compounds adoption directly: European Union good laboratory practice guidance is pushing institutions toward validated, documented sourcing well ahead of most other global markets tracked in this report. Growth trails East Asia and South Asia and Pacific because the region's mature research base is expanding spending more slowly than newer market entrants, and Switzerland contributes smaller but steadily growing demand of its own.
Share: 23% | CAGR: 4.9% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
laboratory-supplies-market-country-cagr-analysis-1787304686754

Where Laboratory Supply Vendors Actually Capture Margin

Standard plasticware sales increasingly compete on price alone as more suppliers enter the category, so the vendors protecting margin monetize the certification and logistics layer: traceability documentation, automation-compatible formulation, and long-term supply agreements. The four levers below reflect where MMA's interviews with laboratory procurement teams show real, sustained willingness to pay a premium across every major decision.

Traceability and Sterility Certification Program Licensing

Laboratories increasingly require documented sterility validation and batch-level traceability certification before approving consumable suppliers, and vendors that invest in rigorous third-party validation are converting what used to be a purely price-based purchasing decision into a certified supplier relationship commanding meaningful premium pricing over uncertified alternatives. This is becoming the primary differentiator in regulated research procurement, where institutions increasingly select vendors based on certification depth rather than unit cost alone, and MMA interviews suggest certified suppliers capture roughly 24% higher recurring revenue per account across the category overall today across most accounts served.
Market Impact: Adds 24 percent higher recurring re

Automation-Compatible Consumable Formulation and Support Services

Suppliers increasingly develop low-retention, automation-validated consumable formulations engineered specifically for robotic liquid handling platforms rather than selling standard manual-format products, since automation compatibility increasingly determines whether a laboratory can rely on a supplier for high-throughput translational research workflows. Suppliers offering validated automation-compatible formats capture meaningfully higher lifetime account value than standard-format vendors, worth roughly 21% more per account relationship over a multi-year contract, since formulation investment builds specification loyalty that pure price competition cannot replicate. Adoption of these automation-validated lines continues accelerating as more laboratories convert manual workflows to robotic platforms.
Market Impact: Adds 21 percent higher lifetime acc

Long-Term Supply and Distribution Agreement Programs

Large research institutions increasingly sign multi-year consumable supply agreements guaranteeing consistent product availability and predictable per-unit pricing throughout an extended procurement relationship, converting what used to be a series of individual purchase orders into predictable recurring revenue worth roughly 19% of a supplier's forward account revenue across the agreement term. Suppliers offering these agreements gain visibility into future demand that supports continued production investment, while institutions gain protection against supply shortages and pricing volatility on consumables purchased at high recurring volume each procurement cycle across their networks, facilities, and affiliated campuses.
Market Impact: Locks in supply revenue for 3 to 5

Institutional Inventory Management and Logistics Services

Suppliers offering integrated inventory management systems, including automated reordering and just-in-time delivery coordination, capture recurring service revenue while simultaneously deepening customer relationships that make competitive displacement more difficult for rivals without comparable logistics infrastructure available today across the category and its supplier base. For institutions managing multi-laboratory consumable budgets, the value proposition is reduced administrative burden without separate inventory tracking system procurement processes across multiple sites and campuses. Early adopters report logistics service attach rates approaching 27% among first-time large institutional buyers, growing steadily each year across the broader category.
Market Impact: Reaches nearly 27 percent logistics

Who Controls the Margin Pool

CR5 sits at 39%, reflecting a category meaningfully fragmented among large diversified life sciences suppliers, evaluated here on a revenue basis across plasticware, glassware, filtration, and consumable product lines combined. Thermo Fisher Scientific and Merck KGaA lead on category revenue scale, with a moderate gap separating them from smaller challengers, including Avantor and Corning, each strong in specific segments rather than universally. Smaller suppliers increasingly struggle to match
Current activity centers on three dimensions: traceability and sterility certification depth, automation-compatible formulation capability, and long-term supply agreement structuring for large institutional accounts. Suppliers lacking single-use filtration production capacity are increasingly partnering with specialty consumable manufacturers rather than losing procurement tenders on missing-product grounds alone across the industry.

Emerging pressure comes from Chinese and Indian domestic manufacturers expanding aggressively on price into mid-market plasticware segments historically dominated by Western suppliers. If these manufacturers continue converting domestic scale into export competitiveness, expect rankings among the next several challengers to shift by 2030, as lower-cost entrants displace slower-moving incumbents across price-sensitive laboratory segments worldwide. Established leaders have limited time to respond before meaningful share shifts occur.
laboratory-supplies-market-company-positioning-matrix-1787304687284

Competitive Moat and Risk Dimensions

THERMO FISHER SCIENTIFIC INC.

Moat: Integrated Consumable Portfolio Depth

Thermo Fisher's broad, integrated consumable portfolio spanning plasticware, filtration, and liquid handling products gives it switching-cost advantages that narrower single-product vendors cannot easily replicate across a laboratory's full procurement relationship. That combined portfolio breadth makes Thermo Fisher a default vendor for institutions seeking a single integrated consumable supply relationship.
THERMO FISHER SCIENTIFIC INC.

Risk: Premium Pricing Competitive Exposure

Thermo Fisher's premium consumable pricing leaves it more exposed than lower-cost competitors to smaller academic institutions and cost-sensitive laboratories evaluating procurement against tighter grant budget availability. Managing this requires balancing continued premium positioning against broader market accessibility across the full range of research accounts served.
MERCK KGAA

Moat: Established Filtration and Bioprocessing Depth

Merck KGaA's decades of filtration and bioprocessing consumable manufacturing history give it validated sterility documentation depth and clinical trial supply chain credibility that newer entrants cannot quickly replicate regardless of technical investment committed. That accumulated regulatory relationship increasingly functions as a competitive moat for large biopharma procurement decisions specifically.
MERCK KGAA

Risk: Standard Plasticware Segment Gap

Merck KGaA's premium filtration focus leaves it more exposed than diversified competitors to institutions seeking a single vendor relationship spanning both premium filtration and standard everyday plasticware consumables. Closing this gap requires either broader product line investment or acquisition of standard consumable manufacturers with established distribution reach.

Players Tracked

Prominent Players

Thermo Fisher Scientific Inc.
Merck KGaA
Avantor, Inc.
Corning Incorporated
Eppendorf SE

Other Key Players

Sartorius AG
Bio-Rad Laboratories, Inc.
Danaher Corporation
Greiner Bio-One International GmbH
Sarstedt AG & Co. KG
Cole-Parmer Instrument Company LLC
Labcon North America
Azenta Life Sciences
Kimble Chase Life Science and Research Products LLC
DWK Life Sciences GmbH
Cardinal Health, Inc.
Hamilton Company
BRAND GMBH + CO KG
Revvity, Inc.
Nichiryo Co., Ltd.

Recent Developments

FEBRUARY 2025

Thermo Fisher Scientific Expands Single-Use Filtration Manufacturing Capacity

Thermo Fisher Scientific announced expanded single-use filtration manufacturing capacity at an existing North American facility, broadening its addressable bioprocessing consumable volume ahead of continued cell and gene therapy research growth. The expansion targets biopharma laboratories seeking certified sterile alternatives across multiple regional markets, nationwide, starting this year.
Signal: Signals Thermo Fisher prioritizing single-
JUNE 2025

Merck KGaA Launches Expanded Automation-Compatible Consumable Line

Merck KGaA announced commercial launch of an expanded low-retention, automation-compatible consumable product line engineered for high-throughput robotic liquid handling platforms, targeting laboratories scaling translational research workflows. The launch follows favorable validation data shared with several major research accounts recently across multiple regions and facility types.
Signal: Signals Merck KGaA prioritizing automation
OCTOBER 2025

Avantor Signs Distribution Agreement With Indian Contract Research Network

Avantor signed a multi-year distribution agreement with a major Indian contract research organization network, securing preferred-supplier status for certified laboratory consumables ahead of the region's expanding biopharma manufacturing investment. The agreement covers plasticware and filtration supply across the network's growing facility portfolio starting this year.
Signal: Signals large suppliers actively pursuing

Polymer Resin and Specialty Glass Feedstock Costs

Polymer resin and specialty borosilicate glass feedstock together account for roughly 36% of laboratory supplies cost of goods sold, making these inputs the dominant cost driver in the category ahead of general molding and assembly labor. Resin and glass costs vary substantially by product specification, with medical-grade purity requirements driving most of the cost variability suppliers face.
Polymer resin costs spiked through 2022 as broader medical device and packaging industry demand absorbed available specialized resin production capacity faster than new capacity could be added, according to company disclosures citing constrained resin availability across multiple regional markets. Suppliers without long-term resin supply agreements or in-house compounding capability saw costs rise faster than they could pass through to fixed-price institutional contract pricing signed before the spike occurred across the industry.

Smaller suppliers without established resin sourcing relationships absorb input cost volatility directly into thin margins, while larger players like Thermo Fisher Scientific and Merck KGaA use existing polymer supply chain relationships to insulate margins from feedstock cost swings. Suppliers newly entering the category without comparable established supply relationships carry meaningfully greater cost exposure than incumbents who capture more of the value chain themselves across the broader category.
laboratory-supplies-market-cost-volatility-analysis-1787304687481

Long-Term Resin and Glass Supply Agreements

The largest suppliers are locking multi-year polymer resin and specialty glass supply agreements directly with production partners rather than competing for spot market volume, securing priority access and more predictable pricing across major production programs and forecast cycles ahead, reinforcing the scale advantages already present across the category and its narrow overall supply base.

Vertical Integration Into Resin Compounding

Larger suppliers are investing directly in in-house resin compounding capability rather than relying entirely on third-party polymer producers, capturing more of the value chain and reducing exposure to feedstock price swings across the category's highest-volume plasticware lines. This trend continues strengthening steadily as demand for certified consumables keeps expanding across every major regional market tracked.

Feedstock Sourcing Diversification Strategies

Suppliers are diversifying resin and glass sourcing across multiple regional producers rather than depending on a single feedstock source, reducing exposure to specific production disruptions that have affected particular material categories during recent volatility episodes across markets. This diversification has become standard practice among the category's larger suppliers over the past several procurement cycles industry-wide.

Portfolio Architecture for Margin Defence

MMA's tier architecture separates the category into three margin bands. Volume and commodity-adjacent standard plasticware and glassware compete on price against widely available generic formats and carry thin margin, premium and certified single-use and automation-compatible consumables carry higher margin on documented sterility and formulation evidence, and sustainability-linked next-generation formats, including recyclable and bio-based plasticware, command the highest margin as the newest,
The tension between volume and premium plays out most visibly among mid-sized academic laboratories, who want certified single-use consumables at closer to standard pricing. That up-tier migration remains slow given how many mid-sized labs still evaluate grant budget cost cautiously before committing further procurement resources each cycle. Suppliers that fail to bundle certification and logistics services risk losing share to more capable rivals.

High-value margin pools concentrate in large institutional account agreements bundled with certification, automation-compatible formulation, and long-term supply agreements, where recurring certification and logistics-attach revenue increasingly outweighs the margin earned on any individual consumable sale alone. That concentration is pulling investment steadily toward certification capability and logistics coordination rather than incremental manufacturing capacity expansion alone across the category, and this trend appears likely to continue strengthening in the years ahead.

Volume / Commodity-Adjacent Tier

Standard plasticware and glassware sold primarily on price against widely available generic formats, serving cost-sensitive academic laboratories where gross margin stays thin and competition is driven almost entirely by landed unit cost.
Gross Margin: 13%-17%

Premium / Certified Tier

Single-use and automation-compatible consumables specified by laboratories requiring documented sterility evidence, formulation validation, and long-term supply agreements, commanding meaningfully higher margin on demonstrated performance achieved across every major procurement market worldwide today.
Gross Margin: 24%-29%

Sustainability / Regulatory / Next-Generation Tier

Recyclable and bio-based plasticware formats positioned for institutions chasing sustainability credentials and performance parity with standard consumables, where material innovation and certification depth support the category's highest margin overall across most major markets today.
Gross Margin: 30%-36%
laboratory-supplies-market-portfolio-architecture-1787304687984

Institutional Procurement and Certification Economics

A consumable sale is rarely a single transaction for the largest institutional accounts. Certification programs, automation-compatible formulation, and long-term supply agreements convert what used to be a one-time purchase order into a relationship spanning years of recurring reorder cycles. Suppliers that capture the certification and logistics attachment at first sale retain more lifetime value per account than those competing on unit price alone.
Adoption depth varies sharply by institution type. Large biopharma and contract research organizations convert fastest and most completely, standardizing entire procurement specifications onto certified, proven suppliers once regulatory pressure and internal quality standards align, making them the highest-value account type despite competitive pricing negotiated across the relationship. Smaller academic laboratories convert more slowly, often relying on standard consumables for years before adopting certified or automation-compatible formats directly.

A generational shift in laboratory managers is compounding the certification-driven shift. Younger laboratory managers entering practice increasingly expect certified, traceable consumables as standard procurement criteria, a requirement an older generation of managers, who trained primarily on cost-per-unit optimization alone, rarely weighted as heavily. That shift is accelerating premium-tier adoption even among institutions that have not yet faced direct regulatory pressure to convert away from standard consumables nearby.
laboratory-supplies-market-end-use-penetration-index-1787304688474

What Matters Most Through 2036

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / SINGLE-USE CAPACITY INVESTMENT

Build certified single-use capacity ahead of the next research wave

Single-use filtration and plasticware demand continues outpacing manufacturing capacity across the category, and suppliers that scale certified production ahead of demand are already capturing disproportionate share of new institutional accounts ahead of competitors still constrained by capacity limitations. Suppliers that invest in manufacturing scale-up now will secure preferred-vendor status with major research accounts before competitors catch up on the capital investment required. Continuing to treat manufacturing capacity as a secondary concern risks ceding the fastest-growing, most differentiated segment to competitors already solving the supply constraint.
02 / AUTOMATION FORMULATION DEPTH

Deepen automation-compatible formulation ahead of the next platform cycle

Automation-compatible consumable formulation increasingly decides purchasing decisions as much as unit price itself, and suppliers that deepen validated formulation pathways will capture disproportionate share of installed base upgrades as laboratories seek high-throughput reliability without full workflow redesign. Suppliers that invest in rigorous, validated formulation now will build switching costs that protect account relationships better than competitors relying on price alone. This formulation investment requires sustained development spending across multiple years before any single platform cycle fully rewards that patient positioning choice.
03 / RECURRING LOGISTICS REVENUE CAPTURE

Bundle certification and logistics into every large institutional quote

Certification programs and long-term supply agreements already generate meaningfully higher recurring revenue than standard consumable sales, yet many suppliers still sell these as separate negotiations rather than a default part of every quote presented to large institutional buyers. Suppliers that make certification and logistics attachment the default, requiring buyers to actively opt out rather than opt in, will capture materially more lifetime value per account than competitors treating these services as an afterthought. This remains underexploited by nearly every supplier outside the two largest players active today.
04 / ASIAN MANUFACTURING COMPETITION

Diversify toward certified segments ahead of continued Asian price pressure

Chinese and Indian domestic manufacturers continue expanding aggressively into mid-market plasticware segments, and suppliers overly dependent on undifferentiated consumable sales into price-sensitive markets face real margin compression risk across the forecast period covered in this report. Suppliers that diversify toward certified, differentiated formulation and logistics sales in segments less exposed to Asian price competition will protect margin better than competitors continuing to compete primarily on undifferentiated commodity-grade consumable price. This repositioning requires sustained investment in certification well before oversupply pressure fully materializes in each affected market.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Laboratory Supplies Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Laboratory Supplies Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a multi-site academic research network operating 7 affiliated research campuses, with a large existing biopharma-adjacent translational research program and a stated goal of standardizing consumable procurement across all affiliated laboratories. Annual laboratory supplies procurement spend exceeds $34 million (client-reported, unverified by MMA), concentrated primarily across plasticware, filtration, and liquid handling consumables nationwide.
STRATEGIC CHALLENGE
The client faced a supplier consolidation decision balancing procurement standardization benefits against existing decentralized purchasing relationships and uncertain cost savings across campuses with varying research volume, specialization, and existing vendor contracts spanning multiple decades. Leadership needed a structured evaluation framework weighing standardization benefits against disruption risk across its diverse campus network.
MMA APPROACH
MMA conducted a structured evaluation of the client's current supplier base against consolidation readiness and cost benchmarking data across its procurement categories, benchmarked vendor-reported certification claims against MMA's proprietary laboratory consumables performance database, and facilitated reference site visits with comparable academic research networks that had already consolidated successfully. The engagement combined primary interviews with the client's procurement leadership alongside independent cost verification.
KEY FINDINGS
  1. Three of the client's seven campuses operated on supplier agreements with meaningfully higher unit pricing than the network's negotiated master agreement terms allowed for across the board.
  2. The client's translational research campuses showed disproportionately higher single-use filtration consumption than its more traditional academic campuses did over the same period.
  3. Consolidating procurement onto certified master suppliers reduced projected annual consumable spend by an estimated 17%, per MMA's proprietary forecasting model and methodology.
  4. Campus-specific research specialization emerged as a meaningfully underestimated factor in supplier selection requiring further detailed analysis before the full network rollout began in earnest.
CLIENT PROFILE
The client is a multi-site academic research network operating 7 affiliated research campuses, with a large existing biopharma-adjacent translational research program and a stated goal of standardizing consumable procurement across all affiliated laboratories. Annual laboratory supplies procurement spend exceeds $34 million (client-reported, unverified by MMA), concentrated primarily across plasticware, filtration, and liquid handling consumables nationwide.
STRATEGIC CHALLENGE
The client faced a supplier consolidation decision balancing procurement standardization benefits against existing decentralized purchasing relationships and uncertain cost savings across campuses with varying research volume, specialization, and existing vendor contracts spanning multiple decades. Leadership needed a structured evaluation framework weighing standardization benefits against disruption risk across its diverse campus network.
MMA APPROACH
MMA conducted a structured evaluation of the client's current supplier base against consolidation readiness and cost benchmarking data across its procurement categories, benchmarked vendor-reported certification claims against MMA's proprietary laboratory consumables performance database, and facilitated reference site visits with comparable academic research networks that had already consolidated successfully. The engagement combined primary interviews with the client's procurement leadership alongside independent cost verification.
KEY FINDINGS
  1. Three of the client's seven campuses operated on supplier agreements with meaningfully higher unit pricing than the network's negotiated master agreement terms allowed for across the board.
  2. The client's translational research campuses showed disproportionately higher single-use filtration consumption than its more traditional academic campuses did over the same period.
  3. Consolidating procurement onto certified master suppliers reduced projected annual consumable spend by an estimated 17%, per MMA's proprietary forecasting model and methodology.
  4. Campus-specific research specialization emerged as a meaningfully underestimated factor in supplier selection requiring further detailed analysis before the full network rollout began in earnest.
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1 to 4): Complete campus-level procurement audit and consolidate the three highest-spend campuses onto master supplier agreements first. Phase 2: Phase 2 (Months 5 to 11): Deploy standardized ordering systems while closely tracking cost savings against baseline campus-level spending metrics. Phase 3: Phase 3 (Months 12 to 18): Expand consolidation across remaining campuses pending validated cost savings from the initial deployment phase.
OUTCOME
The client's first three campuses achieved measurable procurement cost reductions within seven months of consolidation completion (client-reported, unverified by MMA), supporting the phased network-wide rollout that had originally motivated the procurement audit engagement. The remaining four campuses are scheduled for phased consolidation over the following eighteen months.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Laboratory Supplies Market?

MMA estimates the global laboratory supplies market at $48.5 billion in 2025. Growth concentrates in filtration and liquid handling consumables, driven by biopharma research investment and single-use conversion.

How large will the Laboratory Supplies Market be by 2036?

MMA forecasts the market reaching $96.0 billion by 2036, up from $51.6 billion in 2026. That represents roughly a 1.86 times expansion over the full ten-year forecast period covered.

What is the CAGR for the Laboratory Supplies Market 2026 to 2036?

MMA's base case forecasts a 6.4% compound annual growth rate, with a bull case of 7.6% and a bear case of 5.2% depending on biopharma research funding timing.

Which segment is growing fastest?

Filtration products lead at a 9.8% CAGR, roughly 1.5 times the overall market rate, as biopharma laboratories convert bioprocessing workflows toward single-use, pre-sterilized formats across facilities.

Who are the major companies in the Laboratory Supplies Market?

Thermo Fisher Scientific, Merck KGaA, Avantor, Corning, and Eppendorf lead the category, together holding an estimated 39% combined share on a revenue basis worldwide across product lines.

Which country is growing fastest?

India leads at an estimated 10.2% CAGR, outpacing the global average as its expanding contract research and biopharma manufacturing sector continues growing faster than any comparable economy.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Product Type

  • Plasticware and Labware Consumables
  • Glassware
  • Filtration Products
  • Pipettes and Liquid Handling Consumables
  • Storage and Cryogenic Supplies
  • Personal Protective Equipment and Cleanroom Supplies

By End-Use Industry

  • Biopharma and Biotechnology Research
  • Academic and Government Research
  • Contract Research Organizations
  • Clinical and Diagnostic Laboratories

By Commercial Dimension

  • Direct Institutional Procurement
  • Distributor and Reseller Channels
  • Long-Term Supply Contracts
  • Group Purchasing Organization Agreements

By Region

  • North America
  • Western Europe
  • East Asia
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, August 2026)
Market Definition
The laboratory supplies market covers plasticware and labware consumables, glassware, filtration products, pipettes and liquid handling consumables, storage and cryogenic supplies, and personal protective equipment and cleanroom supplies used in academic, biopharma, and clinical research laboratories. It excludes capital laboratory instrumentation such as incubators, centrifuges, and analytical instruments, and excludes reagents and diagnostic assay kits sold as standalone chemical products.
Quantitative Units
USD billions (current prices); unit shipment volume by product category where applicable
Segmentation Dimensions
By Product Type; By End-Use Industry; By Commercial Dimension; By Region
Regions Covered
North America, Western Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
USA, China, Germany, France, UK, Japan, South Korea, India, Australia, Canada, Brazil, Mexico, Indonesia, Vietnam, Thailand, Singapore, UAE, Saudi Arabia, South Africa, Nigeria, Turkey, Poland, Netherlands, Italy, Spain, Sweden, Switzerland, Argentina, Colombia, and additional markets relevant to this sector
Key Companies Profiled
Thermo Fisher Scientific Inc., Merck KGaA, Avantor, Inc., Corning Incorporated, Eppendorf SE, Sartorius AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Greiner Bio-One International GmbH, Sarstedt AG & Co. KG, Cole-Parmer Instrument Company LLC, Labcon North America, Azenta Life Sciences, Kimble Chase Life Science and Research Products LLC, DWK Life Sciences GmbH, Cardinal Health, Inc., Hamilton Company, BRAND GMBH + CO KG, Revvity, Inc., Nichiryo Co., Ltd.
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-MED-101
Published
August 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Laboratory Supplies Market Report (2026 to 2036).

The full Laboratory Supplies Market report delivers granular five-year and ten-year forecasts across all six product segments, institutional procurement tracking by region, and supplier benchmarking drawn from MMA's proprietary laboratory consumables database. It includes detailed profiles of all twenty companies covered here, extended regional analysis across every major research market worldwide, and a regulatory tracker spanning biosafety and good laboratory practice requirements. Subscribers receive quarterly data refreshes through the full forecast period. Buyers also gain direct analyst access for engagement-specific questions throughout the subscription term.
Institutional procurement tracker by region and segment
Ten-year segment-level forecasts across all product types
Supplier benchmarking data across pricing and capacity
Biosafety and certification requirement tracking module
Twenty-company competitive profiles with moat analysis
Quarterly data refresh access throughout subscription term

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts